Pacira BioSciences, Inc. made company filings with the SEC and an analyst raised the stock rating on August 18, 2026.
2 reports, 1 independent
Updated Aug 18
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pacira BioSciences, Inc. made company filings with the SEC and an analyst raised the stock rating on August 18, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sell
German badminton player
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
Related events
- A company filed disclosures with the SEC, and a bank subsequently issued rating and price targets.
- Ionis Pharmaceuticals filed institutional investment disclosures and received analyst rating coverage on August 30, 2026.
- Analyst ratings disclosed via SEC filing involving Morgan Stanley, Royal Bank of Canada, and the SEC.
- Royal Bank of Canada increased its stock holdings in Option Care Health, Inc., which trades on the Nasdaq exchange, and the company filed disclosures with the SEC.
- Houlihan Lokey disclosed insider trading via SEC filing while Royal Bank of Canada increased its stake in the company's stock.